Anti-TNF Therapy During the SARS-CoV-2 Pandemic: Friend or Foe?

J Crohns Colitis. 2022 May 10;16(4):517-518. doi: 10.1093/ecco-jcc/jjab167.
No abstract available

Publication types

  • Editorial

MeSH terms

  • COVID-19*
  • Humans
  • Immunotherapy
  • Pandemics
  • SARS-CoV-2*
  • Tumor Necrosis Factor Inhibitors / therapeutic use

Substances

  • Tumor Necrosis Factor Inhibitors